The natural product lapiferin inhibits cell proliferation and promotes cell apoptosis in gingival squamous cell carcinoma via P21 regulation

Liu,Lin; Peng,Cheng; Ruan,Yan; Zhang,Qian

doi:10.3892/mmr.2021.12121

The natural product lapiferin inhibits cell proliferation and promotes cell apoptosis in gingival squamous cell carcinoma via P21 regulation

Authors:
- Lin Liu
- Cheng Peng
- Yan Ruan
- Qian Zhang
View Affiliations

Affiliations: Department of Stomatology, The Second Hospital of Tianjin Medical University, Tianjin 300211, P.R. China, Department of Stomatology, School and Hospital of Stomatology, Tianjin Medical University, Tianjin 300070, P.R. China
Published online on: April 26, 2021 https://doi.org/10.3892/mmr.2021.12121
Article Number: 482
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gingival squamous cell carcinoma (GSCC) is responsible fora large proportion of oral cavity malignancies. GSCC is characterized by rapid cell growth, and progressive invasion and migration. P21 is a widely recognized tumor suppressor, which is induced by P53 activation; however, drugs that aim to promote P21‑mediated tumor suppression remain to be identified. A natural compound library was used to perform broad‑spectrum screening of drugs that could promote P21 expression. Subsequently, the effects of the screened drug on GSCC cell proliferation and apoptosis were evaluated. The results of the present study suggested that lapiferin was the most effective natural compound that promoted the expression of P21 at both mRNA and protein levels. Lapiferin inhibited proliferation and enhanced apoptosis of YD‑38 GSCC cells in a dose‑dependent manner. Furthermore, following treatment with lapiferin, the critical cell cycle regulators cell division cycle 25C and cyclin B1 and tumor cell proliferation markers proliferating cell nuclear antigen and Ki67 were markedly decreased. In addition, pro‑apoptotic proteins were promoted following treatment of YD‑38 cells with lapiferin. Following the depletion ofP21 expression, lapiferin‑mediated inhibition of cell proliferation and enhancement of cell apoptosis were significantly reduced. These results indicated that lapiferin may exert potent antitumor effects on GSCC via regulation of P21; therefore, lapiferin may be considered a potential, natural therapeutic agent for the treatment of GSCC.

View Figures

View References

1	Gong Y, Yang H and Tian X: Elucidating the mechanism of miRNA-214 in the regulation of gingival carcinoma. Exp Ther Med. 13:2544–2550. 2017. View Article : Google Scholar : PubMed/NCBI
2	Keshava A, Gugwad S, Baad R and Patel R: Gingival squamous cell carcinoma mimicking as a desquamative lesion. J Indian Soc Periodontol. 20:75–78. 2016. View Article : Google Scholar : PubMed/NCBI
3	Okura M, Yanamoto S, Umeda M, Otsuru M, Ota Y, Kurita H, Kamata T, Kirita T, Yamakawa N, Yamashita T, et al: Prognostic and staging implications of mandibular canal invasion in lower gingival squamous cell carcinoma. Cancer Med. 5:3378–3385. 2016. View Article : Google Scholar : PubMed/NCBI
4	Hinchy NV, Jayaprakash V, Rigual N, Reid M, Frustino JL, Rossitto R, Groman A and Sullivan MA: Progression of gingival squamous cell carcinoma from early to late stage after invasive dental procedure. Gen Dent. 64:38–43. 2016.PubMed/NCBI
5	Fitzpatrick SG, Neuman AN, Cohen DM and Bhattacharyya I: Papillary variant of squamous cell carcinoma arising on the gingiva: 61 cases reported from within a larger series of gingival squamous cell carcinoma. Head Neck Pathol. 7:320–326. 2013. View Article : Google Scholar : PubMed/NCBI
6	Choi EJ, Zhang X, Kim HJ, Nam W and Cha IH: Prognosis of gingival squamous cell carcinoma diagnosed after invasive procedures. Asian Pac J Cancer Prev. 12:2649–2652. 2011.PubMed/NCBI
7	Zhang F, Duan S, Tsai Y, Keng PC and Chen Y, Lee SO and Chen Y: Cisplatin treatment increases stemness through upregulation of hypoxia-inducible factors by interleukin-6 in non-small cell lung cancer. Cancer Sci. 107:746–754. 2016. View Article : Google Scholar : PubMed/NCBI
8	Gao Y, Shan N, Zhao C, Wang Y, Xu F, Li J, Yu X, Gao L and Yi Z: LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells. Int J Clin Exp Pathol. 8:4923–4932. 2015.PubMed/NCBI
9	Florea AM and Büsselberg D: Cisplatin as an anti-tumor drug: Cellular mechanisms of activity, drug resistance and induced side effects. Cancers (Basel). 3:1351–1371. 2011. View Article : Google Scholar : PubMed/NCBI
10	Huang C and Yu Y: Synergistic cytotoxicity of β-elemene and cisplatin in gingival squamous cell carcinoma by inhibition of STAT3 signaling pathway. Med Sci Monit. 23:1507–1513. 2017. View Article : Google Scholar : PubMed/NCBI
11	Yang X, Tang C, Luo H, Wang H and Zhou X: Shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798. Oncotarget. 8:23664–23674. 2017. View Article : Google Scholar : PubMed/NCBI
12	Zhu X, Jiang H, Li J, Xu J and Fei Z: Anticancer effects of paris saponins by apoptosis and PI3K/AKT pathway in gefitinib-resistant non-small cell lung cancer. Med Sci Monit. 22:1435–1441. 2016. View Article : Google Scholar : PubMed/NCBI
13	Zhao PJ, Song SC, Du LW, Zhou GH, Ma SL, Li JH, Feng JG, Zhu XH and Jiang H: Paris Saponins enhance radiosensitivity in a gefitinib-resistant lung adenocarcinoma cell line by inducing apoptosis and G2/M cell cycle phase arrest. Mol Med Rep. 13:2878–2884. 2016. View Article : Google Scholar : PubMed/NCBI
14	Song S, Du L, Jiang H, Zhu X, Li J and Xu J: Paris saponin I sensitizes gastric cancer cell lines to cisplatin via cell cycle arrest and apoptosis. Med Sci Monit. 22:3798–3803. 2016. View Article : Google Scholar : PubMed/NCBI
15	Jiang H, Zhao PJ, Su D, Feng J and Ma SL: Paris saponin I induces apoptosis via increasing the Bax/Bcl-2 ratio and caspase-3 expression in gefitinib-resistant non-small cell lung cancer in vitro and in vivo. Mol Med Rep. 9:2265–2272. 2014. View Article : Google Scholar : PubMed/NCBI
16	el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell. 75:817–825. 1993. View Article : Google Scholar : PubMed/NCBI
17	el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, et al: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1169–1174. 1994.PubMed/NCBI
18	El-Deiry WS: p21(WAF1) mediates cell-cycle inhibition, relevant to cancer suppression and therapy. Cancer Res. 76:5189–5191. 2016. View Article : Google Scholar : PubMed/NCBI
19	Georgakilas AG, Martin OA and Bonner WM: p21: A two-faced genome guardian. Trends Mol Med. 23:310–319. 2017. View Article : Google Scholar : PubMed/NCBI
20	Poli F, Appendino G, Sacchetti G, Ballero M, Maggiano N and Ranelletti FO: Antiproliferative effects of daucane esters from Ferula communis and F. arrigonii on human colon cancer cell lines. Phytother Res. 19:152–157. 2005. View Article : Google Scholar : PubMed/NCBI
21	Abbasi-Kenarsari H, Shafaghat F, Baradaran B, Movassaghpour AA, Shanehbandi D and Kazemi T: Cloning and expression of CD19, a human B-cell marker in NIH-3T3 cell line. Avicenna J Med Biotechnol. 7:39–44. 2015.PubMed/NCBI
22	Zhang L, Lin J, Ma Y, Wei D and Sun M: Construction of a novel shuttle vector for use in Gluconobacter oxydans. Mol Biotechnol. 46:227–233. 2010. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
24	Hoffman HT, Karnell LH, Funk GF, Robinson RA and Menck HR: The national cancer data base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg. 124:951–962. 1998. View Article : Google Scholar : PubMed/NCBI
25	Yoon TY, Bhattacharyya I, Katz J, Towle HJ and Islam MN: Squamous cell carcinoma of the gingiva presenting as localized periodontal disease. Quintessence Int. 38:97–102. 2007.PubMed/NCBI
26	Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D: p21 is a universal inhibitor of cyclin kinases. Nature. 366:701–704. 1993. View Article : Google Scholar : PubMed/NCBI
27	Gartel AL and Radhakrishnan SK: Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res. 65:3980–3985. 2005. View Article : Google Scholar : PubMed/NCBI
28	Abramov AY, Zamaraeva MV, Hagelgans AI, Azimov RR and Krasilnikov OV: Influence of plant terpenoids on the permeability of mitochondria and lipid bilayers. Biochim Biophys Acta. 1512:98–110. 2001. View Article : Google Scholar : PubMed/NCBI
29	Golovina LA, Saidkhodzhaev AI, Abdullaev ND, Malikov VM and Yagudaev MR: Structure and stereochemistry of lapiferin. Chem Nat Compd. 19:281–285. 1983. View Article : Google Scholar
30	Gamal-Eldeen AM and Hegazy ME: A crystal lapiferin derived from Ferula vesceritensis induces apoptosis pathway in MCF-7 breast cancer cells. Nat Prod Res. 24:246–257. 2010. View Article : Google Scholar : PubMed/NCBI
31	Kademani D: Oral cancer. Mayo Clin Proc. 82:878–887. 2007. View Article : Google Scholar : PubMed/NCBI